| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037467863 |
| P356 | DOI | 10.1038/ONC.2015.264 |
| P698 | PubMed publication ID | 26148234 |
| P50 | author | Michael J Ausserlechner | Q64683337 |
| Judith Hagenbuchner | Q82408236 | ||
| P2093 | author name string | U Kiechl-Kohlendorfer | |
| P Obexer | |||
| P2860 | cites work | Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement | Q22254394 |
| Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis | Q24338917 | ||
| Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family | Q24670396 | ||
| Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy | Q28131727 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| The Beclin 1 network regulates autophagy and apoptosis | Q29616539 | ||
| Autophagy in health and disease: a double-edged sword | Q29618103 | ||
| Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study | Q32142109 | ||
| Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. | Q33459240 | ||
| Regulation of survivin function by Hsp90 | Q33713035 | ||
| Differential requirements for survivin in hematopoietic cell development | Q33913884 | ||
| A role for survivin in chemoresistance of endothelial cells mediated by VEGF | Q34047896 | ||
| Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies | Q34081705 | ||
| Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin | Q34323688 | ||
| High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein | Q41072145 | ||
| Glucose-starved cells do not engage in prosurvival autophagy | Q41924376 | ||
| Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions | Q44647527 | ||
| FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. | Q45100601 | ||
| Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin | Q46825564 | ||
| A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. | Q50718091 | ||
| YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. | Q51794884 | ||
| Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. | Q53614823 | ||
| Analysis of human transcriptomes. | Q55033453 | ||
| Selective escape of proteins from the mitochondria during mitophagy | Q61207848 | ||
| High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma | Q63874527 | ||
| Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis | Q64377539 | ||
| The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells | Q74805759 | ||
| Necroptosis in health and diseases | Q34432108 | ||
| Targeting survivin in cancer: novel drug development approaches | Q34954296 | ||
| Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia | Q35182716 | ||
| Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect | Q35239585 | ||
| Survivin, versatile modulation of cell division and apoptosis in cancer | Q35591693 | ||
| Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells | Q35753977 | ||
| Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. | Q35834685 | ||
| Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. | Q35842152 | ||
| FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma | Q35998617 | ||
| Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization | Q36357428 | ||
| Does autophagy contribute to cell death? | Q36549462 | ||
| Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis | Q36746869 | ||
| Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. | Q36907096 | ||
| Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo | Q36930279 | ||
| Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression | Q37513265 | ||
| Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. | Q37574259 | ||
| Autophagy in the cellular energetic balance | Q37870537 | ||
| Mitophagy: a complex mechanism of mitochondrial removal | Q37955193 | ||
| Tumor glycolysis as a target for cancer therapy: progress and prospects | Q38168262 | ||
| Autophagy as a pro-death pathway | Q38261558 | ||
| YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines | Q38932250 | ||
| Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma | Q38989148 | ||
| 2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells | Q39096682 | ||
| A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration | Q39122729 | ||
| 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth | Q39197274 | ||
| BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. | Q39245718 | ||
| 2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma | Q39475175 | ||
| Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. | Q39541632 | ||
| The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy | Q39754547 | ||
| The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. | Q39755661 | ||
| Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis | Q39884717 | ||
| Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models | Q39992667 | ||
| Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. | Q40201823 | ||
| Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. | Q40218927 | ||
| A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer | Q40314536 | ||
| Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors | Q40388768 | ||
| Rational design of shepherdin, a novel anticancer agent. | Q40422406 | ||
| Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity | Q40489168 | ||
| Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. | Q40539259 | ||
| Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited | Q40735665 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2052-2061 | |
| P577 | publication date | 2015-07-06 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma | |
| P478 | volume | 35 |
| Q57478281 | An Apoptotic and Endosymbiotic Explanation of the Warburg and the Inverse Warburg Hypotheses |
| Q92719676 | Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation |
| Q38705079 | Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation |
| Q33730108 | C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy |
| Q50333246 | Cancer Chemoprevention and Piperine: Molecular Mechanisms and Therapeutic Opportunities. |
| Q91879092 | Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155 |
| Q36481398 | Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types. |
| Q38741378 | Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance |
| Q43816387 | FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3. |
| Q37712748 | Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography |
| Q59800398 | Identification of Potential Prognostic Genes for Neuroblastoma |
| Q49892584 | Investigation of major genetic alterations in neuroblastoma. |
| Q42730045 | Mitochondrial survivin - an Achilles' heel in cancer chemoresistance. |
| Q83225642 | Modulating FOXO3 transcriptional activity by small, DBD-binding molecules |
| Q92604888 | Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer |
| Q47235034 | Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance. |
| Q90085168 | Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations |
| Q37718408 | Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma. |
| Q64062728 | Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis |
| Q41520294 | Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate |
| Q92858954 | Survivin at a glance |
| Q90047188 | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines |
| Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
| Q38834089 | The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastoma |
| Q49830952 | Very long-/ and long Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency correlates with deregulation of the mitochondrial fusion/fission machinery. |
Search more.